Apr 2 |
Spectral Medical Chair to Retire From the Board of Directors
|
Apr 1 |
Spectral Medical Full Year 2023 Earnings: Misses Expectations
|
Mar 28 |
Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update
|
Feb 28 |
Spectral Medical Provides February Tigris Trial Update
|
Feb 21 |
Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation
|
Feb 15 |
Spectral Medical Announces Major Milestone by Reaching Its Interim Enrollment Target of 90 Patients
|
Feb 5 |
Spectral Medical Provides Early February Tigris Trial Update
|
Jan 30 |
Spectral Medical Provides January Tigris Trial Update
|
Jan 10 |
Spectral Medical Enrolls Patient 82 in Its Phase 3 FDA Tigris Septic Shock Trial
|
Dec 30 |
Spectral Medical (TSE:EDT) shareholders have earned a 6.2% CAGR over the last five years
|